A CONSTRUCTIVE
CONTRIBUTION TO THE
RESPONSIBLE DEVELOPMENT
AND USE OF ENGINEERED
NANOMATERIALS
nanoRISK
 
Links April 2007 Issue

Page 1
  • The Freedonia Group: "Nanotechnology in Health Care to 2011"
  • Lux Research: "How Nanotechnology Adds Value to Products"
  •  
    Page 2
  • Nano Risk Framework draft (pdf download, 488 KB)
  •  
    Page 3
  • Ludwig, K. et al: "Oxide Nanoparticle Uptake in Human Lung Fibroblasts: Effects of Particle Size, Agglomeration, and Diffusion at Low Concentrations" in: Environ. Sci. Technol.; 2005; 39(23) pp 9370 - 9376;
  • Wick, P. et al: "In vitro evaluation of possible adverse effects of nanosized materials" in: physica status solidi (b); 2006; Volume 243, Issue 13 , Pages 3556 - 3560;
  • Ludwig, K. et al: "The degree and kind of agglomeration affect carbon nanotube cytotoxicity" in: Toxicology Letters; Volume 168, Issue 2 , 30 January 2007, Pages 121-131;
  •  
    Page 4
  • Nanotherapeutics: new challenges for safety and cost-effectiveness regulation in Australian in: The Medical Journal of Australia, Volume 186 Number 4, February 19, 2007; (pdf download)
  • Nanomedicine, Device & Diagnostic Report, NanoBiotech News, 2006
  • SCENIHR public consultation Synthesis Report (pdf download, 234 KB)
  • International Risk Governance Council: "White Paper No. 2: Nanotechnology Risk Governance" (pdf download, 1.2 MB)
  •  
    Page 6
  • The Ethical aspects of Nanomedicine; (pdf download, 1.5 MB)
  • Mnyusiwalla, A. et al: "'Mind the gap': science and ethics in nanotechnology" in: Nanotechnology, 2003, 14 R9-R13;
  • Conferences:
  • Health & Environmental Summit on Nano
  • MICROPOL & ECOHAZARD 2007
  • The 2nd International Congress of Nanobiotechnology & Nanomedicine (NanoBio2007)
  • Nano Toxicity Conference 2007
  • 3rd International Symposium on Nanotechnology, Occupational and Environmental Health
  • Nanobiotechnology and Nano-Medicine - Ethical, Legal and Social Aspects
  • Nanoparticles for European Industry II: Measurement, Characterisation and Standardisation; Manufacturing Scale-Up and Processing; Regulation, Risks and Toxicology
  •  
    Page 7
  • "EPA Nanotechnology White Paper (Final)" (pdf download, 2.6 MB)
  • Fang, J. et al: "Effect of a Fullerene Water Suspension on Bacterial Phospholipids and Membrane Phase Behavior" in: Environ. Sci. Technol.; 2007; 41(7) pp 2636 - 2642;
  • "Thinking Big About Things Small" (pdf download, 604 KB)
  • NIOSH: Progress Toward Safe Nanotechnology in the Workplace (pdf download, 3.17 MB)
  • The Medical Journal of Australia: Nanotechnology: a promising new technology — but how safe
  • ICF International: "Analysis of the U.S. effort to characterize the environmental, health and safety implications of nanotech" (pdf download 1 MB)
  • ICON: "The Virtual Journal of Nanotechnology Environment, Health and Safety"
  • Chang, J-S. et al: "In Vitro Cytotoxicitiy of Silica Nanoparticles at High Concentrations Strongly Depends on the Metabolic Activity Type of the Cell Line" in: Environ. Sci. Technol.; 2007; 41(6) pp 2064 - 2068;
  • Tong, Z. et al: "Impact of Fullerene (C60) on a Soil Microbial Community" in: Environ. Sci. Technol.; 2007; ASAP Web Release Date: 14-Mar-2007;
  • "Nanosafe2 newsletter"
  •  
    Privacy Statement | Terms of Use
    The contents of this site are copyright ©2008, Nanowerk LLC. All Rights Reserved